Isradipine
Generic name: Pronounced as (iz ra' di peen)
Medical Content Reviewed By HelloPharmacist Staff
Last Revised - 11/15/2017
On this page
- Why is this medication prescribed?
- How should this medicine be used?
- Other uses for this medicine
- What special precautions should I follow?
- What special dietary instructions should I follow?
- What should I do if I forget a dose?
- What side effects can this medication cause?
- What should I know about STORAGE and DISPOSAL of this medication?
- What should I do in case of OVERDOSE?
- What OTHER INFORMATION should I know?
- Drug interactions
Why is this medication prescribed?
Isradipine is used to treat high blood pressure. Isradipine is in a class of medications called calcium channel blockers. It works by relaxing the blood vessels so your heart does not have to pump as hard.
High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
How should this medicine be used?
Isradipine comes as a capsule to take by mouth. The capsule is usually taken two times a day. To help you remember to take isradipine, take it around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take isradipine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Isradipine controls high blood pressure but does not cure it. Continue to take isradipine even if you feel well. Do not stop taking isradipine without talking to your doctor.
Other uses for this medicine
This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking isradipine,
-
tell your doctor and pharmacist if you are allergic to isradipine, any other medications, or any ingredients in isradipine capsules. Ask your pharmacist for a list of the ingredients.
-
tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: cimetidine (Tagamet), fentanyl (Duragesic), heart and blood pressure medications such as beta-blockers and diuretics ('water pills'), ranitidine (Zantac), and rifampin (Rifadin, Rimactane).
-
tell your doctor if you have or have ever had heart, liver, or kidney disease.
-
tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking isradipine, call your doctor.
-
if you are having surgery, including dental surgery, tell your doctor or dentist that you are taking isradipine.
What special dietary instructions should I follow?
Talk to your doctor about drinking grapefruit juice or eating grapefruit while taking isradipine.
Talk to your doctor before using salt substitutes containing potassium. If your doctor prescribes a low-salt or low-sodium diet, follow these directions carefully.
What should I do if I forget a dose?
Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
-
Isradipine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
-
headache
-
dizziness or lightheadedness
-
flushing
-
fast heartbeat
-
excessive tiredness
-
upset stomach
-
vomiting
-
diarrhea
-
-
Some side effects can be serious. If you experience any of the following symptoms, call your doctor immediately or get emergency medical treatment:
-
chest pain
-
swelling of the face, eyes, lips, tongue, arms, or legs
-
difficulty breathing or swallowing
-
fainting
-
rash
-
-
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
What should I know about STORAGE and DISPOSAL of this medication?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).
It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org
Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.
What should I do in case of OVERDOSE?
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
What OTHER INFORMATION should I know?
Keep all appointments with your doctor and the laboratory. Your blood pressure should be checked regularly to determine your response to isradipine.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Drug interactions
Drug | Interaction |
---|---|
Moxifloxacin | Moxifloxacin The risk or severity of QTc prolongation can be increased when Isradipine is combined with Moxifloxacin. |
Repaglinide | Repaglinide Isradipine may decrease the excretion rate of Repaglinide which could result in a higher serum level. |
Insulin Glargine (rDNA origin) Injection | Insulin Glargine (rDNA origin) Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin glargine. |
Atorvastatin | Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Isradipine. |
Dolasetron | Dolasetron The risk or severity of QTc prolongation can be increased when Isradipine is combined with Dolasetron. |
Aminophylline | Aminophylline The metabolism of Aminophylline can be decreased when combined with Isradipine. |
Anagrelide | Anagrelide The risk or severity of QTc prolongation can be increased when Isradipine is combined with Anagrelide. |
Bisacodyl | Bisacodyl The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Isradipine. |
Candesartan | Candesartan The risk or severity of hyperkalemia can be increased when Isradipine is combined with Candesartan. |
Cilostazol | Cilostazol The metabolism of Cilostazol can be decreased when combined with Isradipine. |
Clopidogrel | Clopidogrel The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Isradipine. |
Erythromycin and Sulfisoxazole | Erythromycin and Sulfisoxazole The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Isradipine. |
Estrogen and Progestin (Oral Contraceptives) | Estrogen and Progestin (Oral Contraceptives) Isradipine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level. |
Fenofibrate | Fenofibrate The metabolism of Fenofibrate can be decreased when combined with Isradipine. |
Guanfacine | Guanfacine Isradipine may decrease the excretion rate of Guanfacine which could result in a higher serum level. |
Magnesium Gluconate | Magnesium Gluconate The risk or severity of hypotension can be increased when Isradipine is combined with Magnesium gluconate. |
Magnesium Hydroxide | Magnesium Hydroxide The risk or severity of hypotension can be increased when Isradipine is combined with Magnesium hydroxide. |
Magnesium Oxide | Magnesium Oxide The risk or severity of hypotension can be increased when Isradipine is combined with Magnesium oxide. |
Methylergonovine | Methylergonovine Methylergometrine may decrease the antihypertensive activities of Isradipine. |
Miglitol | Miglitol The risk or severity of hypoglycemia can be increased when Isradipine is combined with Miglitol. |
Mycophenolate | Mycophenolate Isradipine may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level. |
Naratriptan | Naratriptan Naratriptan may decrease the antihypertensive activities of Isradipine. |
Olsalazine | Olsalazine Olsalazine may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Paregoric | Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Isradipine. |
Penbutolol | Penbutolol The risk or severity of bradycardia can be increased when Isradipine is combined with Acebutolol. |
Polyethylene glycol-electrolyte solution (PEG-ES) | Polyethylene glycol-electrolyte solution (PEG-ES) The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Isradipine. |
Potassium | Potassium Potassium may increase the excretion rate of Isradipine which could result in a lower serum level and potentially a reduction in efficacy. |
Prednisone | Prednisone Isradipine may decrease the excretion rate of Prednisone which could result in a higher serum level. |
Psyllium | Psyllium The therapeutic efficacy of Plantago seed can be decreased when used in combination with Isradipine. |
Ranitidine | Ranitidine Isradipine may decrease the excretion rate of Ranitidine which could result in a higher serum level. |
Reserpine | Reserpine Reserpine may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Rizatriptan | Rizatriptan Isradipine may decrease the excretion rate of Rizatriptan which could result in a higher serum level. |
Sumatriptan | Sumatriptan Sumatriptan may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Tacrolimus | Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Isradipine. |
Tizanidine | Tizanidine The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Isradipine. |
Zolmitriptan | Zolmitriptan Zolmitriptan may decrease the antihypertensive activities of Isradipine. |
Ampicillin Injection | Ampicillin Injection Isradipine may decrease the excretion rate of Ampicillin which could result in a higher serum level. |
Doxycycline Injection | Doxycycline Injection Doxycycline may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Famotidine Injection | Famotidine Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Famotidine. |
Fluconazole Injection | Fluconazole Injection The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Isradipine. |
Foscarnet Injection | Foscarnet Injection Foscarnet may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Hydromorphone Injection | Hydromorphone Injection Isradipine may decrease the excretion rate of Hydromorphone which could result in a higher serum level. |
Levofloxacin Injection | Levofloxacin Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Levofloxacin. |
Meperidine Injection | Meperidine Injection The metabolism of Meperidine can be decreased when combined with Isradipine. |
Metoclopramide Injection | Metoclopramide Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Metoclopramide. |
Metronidazole Injection | Metronidazole Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Metronidazole. |
Morphine Injection | Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Isradipine. |
Pamidronate Injection | Pamidronate Injection Pamidronic acid may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Vancomycin Injection | Vancomycin Injection Isradipine may decrease the excretion rate of Vancomycin which could result in a higher serum level. |
Altretamine | Altretamine Amphetamine may increase the hypotensive activities of Isradipine. |
Cefuroxime | Cefuroxime Cefuroxime may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Cyclosporine | Cyclosporine The metabolism of Cyclosporine can be decreased when combined with Isradipine. |
Ondansetron | Ondansetron The risk or severity of QTc prolongation can be increased when Isradipine is combined with Ondansetron. |
Enoxaparin Injection | Enoxaparin Injection The risk or severity of hyperkalemia can be increased when Isradipine is combined with Enoxaparin. |
Granisetron | Granisetron The risk or severity of QTc prolongation can be increased when Isradipine is combined with Granisetron. |
Torsemide | Torsemide Torasemide may increase the excretion rate of Isradipine which could result in a lower serum level and potentially a reduction in efficacy. |
Olanzapine | Olanzapine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Olanzapine. |
Dofetilide | Dofetilide Isradipine may increase the arrhythmogenic activities of Dofetilide. |
Eprosartan | Eprosartan The risk or severity of hyperkalemia can be increased when Isradipine is combined with Eprosartan. |
Hydroxychloroquine | Hydroxychloroquine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Hydroxychloroquine. |
Meloxicam | Meloxicam The therapeutic efficacy of Isradipine can be decreased when used in combination with Meloxicam. |
Pantoprazole | Pantoprazole Pantoprazole may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Telmisartan | Telmisartan Isradipine may decrease the excretion rate of Telmisartan which could result in a higher serum level. |
Temozolomide | Temozolomide Isradipine may decrease the excretion rate of Temozolomide which could result in a higher serum level. |
Zaleplon | Zaleplon Isradipine may decrease the excretion rate of Zaleplon which could result in a higher serum level. |
Desloratadine | Desloratadine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Desloratadine. |
Linezolid | Linezolid Linezolid may increase the hypotensive activities of Isradipine. |
Rivastigmine | Rivastigmine Isradipine may increase the bradycardic activities of Rivastigmine. |
Trimipramine | Trimipramine The risk or severity of QTc prolongation can be increased when Trimipramine is combined with Isradipine. |
Perindopril | Perindopril The risk or severity of hyperkalemia can be increased when Isradipine is combined with Perindopril. |
Tenofovir | Tenofovir Tenofovir may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Choline Magnesium Trisalicylate | Choline Magnesium Trisalicylate The therapeutic efficacy of Isradipine can be decreased when used in combination with Choline magnesium trisalicylate. |
Sirolimus | Sirolimus Isradipine may increase the immunosuppressive activities of Sirolimus. |
Dutasteride | Dutasteride Dutasteride may decrease the antihypertensive activities of Isradipine. |
Epinephrine Injection | Epinephrine Injection Epinephrine may decrease the antihypertensive activities of Isradipine. |
Eplerenone | Eplerenone The metabolism of Eplerenone can be decreased when combined with Isradipine. |
Escitalopram | Escitalopram The risk or severity of QTc prolongation can be increased when Isradipine is combined with Escitalopram. |
Olmesartan | Olmesartan Olmesartan may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Zonisamide | Zonisamide Isradipine may increase the arrhythmogenic activities of Zonisamide. |
Aripiprazole | Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Isradipine. |
Atomoxetine | Atomoxetine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Atomoxetine. |
Dexmethylphenidate | Dexmethylphenidate Dexmethylphenidate may decrease the antihypertensive activities of Isradipine. |
Ezetimibe | Ezetimibe Isradipine may decrease the excretion rate of Ezetimibe which could result in a higher serum level. |
Atazanavir | Atazanavir Isradipine may decrease the excretion rate of Atazanavir which could result in a higher serum level. |
Almotriptan | Almotriptan Isradipine may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Eletriptan | Eletriptan Eletriptan may decrease the antihypertensive activities of Isradipine. |
Mefloquine | Mefloquine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Mefloquine. |
Polyethylene Glycol 3350 | Polyethylene Glycol 3350 The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Isradipine. |
Rosuvastatin | Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Isradipine. |
Vardenafil | Vardenafil The metabolism of Vardenafil can be decreased when combined with Isradipine. |
Alfuzosin | Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Isradipine. |
Emtricitabine | Emtricitabine Isradipine may decrease the excretion rate of Emtricitabine which could result in a higher serum level. |
Memantine | Memantine Isradipine may decrease the excretion rate of Memantine which could result in a higher serum level. |
Tegaserod | Tegaserod The therapeutic efficacy of Tegaserod can be decreased when used in combination with Isradipine. |
Tadalafil | Tadalafil Isradipine may increase the antihypertensive activities of Tadalafil. |
Frovatriptan | Frovatriptan Frovatriptan may decrease the antihypertensive activities of Isradipine. |
Gemifloxacin | Gemifloxacin The risk or severity of QTc prolongation can be increased when Isradipine is combined with Gemifloxacin. |
Progesterone | Progesterone Progesterone may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Apomorphine Injection | Apomorphine Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Isradipine. |
Protriptyline | Protriptyline The risk or severity of QTc prolongation can be increased when Isradipine is combined with Protriptyline. |
Duloxetine | Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Isradipine is combined with Duloxetine. |
Norethindrone | Norethindrone The metabolism of Norethisterone can be decreased when combined with Isradipine. |
Tinidazole | Tinidazole Isradipine may decrease the excretion rate of Tinidazole which could result in a higher serum level. |
Bosentan | Bosentan Bosentan may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Cefditoren | Cefditoren Isradipine may decrease the excretion rate of Cefdinir which could result in a higher serum level. |
Cyanocobalamin Injection | Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Erlotinib | Erlotinib The metabolism of Erlotinib can be decreased when combined with Isradipine. |
Eszopiclone | Eszopiclone The metabolism of Eszopiclone can be decreased when combined with Isradipine. |
Ganciclovir | Ganciclovir Isradipine may decrease the excretion rate of Ganciclovir which could result in a higher serum level. |
Insulin Aspart (rDNA Origin) Injection | Insulin Aspart (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin aspart. |
Ribavirin | Ribavirin Isradipine may decrease the excretion rate of Ribavirin which could result in a higher serum level. |
Solifenacin | Solifenacin The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Isradipine. |
Valganciclovir | Valganciclovir Isradipine may decrease the excretion rate of Valganciclovir which could result in a higher serum level. |
Voriconazole | Voriconazole The risk or severity of QTc prolongation can be increased when Isradipine is combined with Voriconazole. |
Adefovir | Adefovir Adefovir may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Dextroamphetamine | Dextroamphetamine Amphetamine may increase the hypotensive activities of Isradipine. |
Pramlintide Injection | Pramlintide Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Pramlintide. |
Exenatide Injection | Exenatide Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Exenatide. |
Ibandronate | Ibandronate The risk or severity of QTc prolongation can be increased when Isradipine is combined with Ibandronate. |
Isocarboxazid | Isocarboxazid Isocarboxazid may increase the hypotensive activities of Isradipine. |
Ramelteon | Ramelteon Isradipine may decrease the excretion rate of Ramelteon which could result in a higher serum level. |
Fentanyl | Fentanyl The metabolism of Fentanyl can be decreased when combined with Isradipine. |
Pregabalin | Pregabalin Pregabalin may increase the arrhythmogenic activities of Isradipine. |
Phenylephrine | Phenylephrine The risk or severity of hypertension can be decreased when Phenylephrine is combined with Isradipine. |
Tipranavir | Tipranavir Tipranavir may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Felbamate | Felbamate The risk or severity of QTc prolongation can be increased when Isradipine is combined with Felbamate. |
Insulin Detemir (rDNA Origin) Injection | Insulin Detemir (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin detemir. |
Ranolazine | Ranolazine The metabolism of Ranolazine can be decreased when combined with Isradipine. |
Rasagiline | Rasagiline Rasagiline may increase the hypotensive activities of Isradipine. |
Imatinib | Imatinib The risk or severity of QTc prolongation can be increased when Isradipine is combined with Imatinib. |
Sitagliptin | Sitagliptin The risk or severity of hypoglycemia can be increased when Isradipine is combined with Sitagliptin. |
Varenicline | Varenicline Isradipine may decrease the excretion rate of Varenicline which could result in a higher serum level. |
Albuterol | Albuterol The risk or severity of QTc prolongation can be increased when Isradipine is combined with Salbutamol. |
Paliperidone | Paliperidone The risk or severity of QTc prolongation can be increased when Isradipine is combined with Paliperidone. |
Bortezomib | Bortezomib The metabolism of Isradipine can be decreased when combined with Bortezomib. |
Clofarabine Injection | Clofarabine Injection Isradipine may decrease the excretion rate of Clofarabine which could result in a higher serum level. |
Insulin Glulisine (rDNA origin) Injection | Insulin Glulisine (rDNA origin) Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin glulisine. |
Lubiprostone | Lubiprostone Isradipine may decrease the excretion rate of Lubiprostone which could result in a higher serum level. |
Oxaliplatin Injection | Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Oxaliplatin. |
Posaconazole | Posaconazole The risk or severity of QTc prolongation can be increased when Isradipine is combined with Posaconazole. |
Primaquine | Primaquine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Primaquine. |
Rituximab Injection | Rituximab Injection Isradipine may increase the hypotensive activities of Rituximab. |
Aliskiren | Aliskiren The risk or severity of hyperkalemia can be increased when Isradipine is combined with Aliskiren. |
Darunavir | Darunavir The serum concentration of Darunavir can be increased when it is combined with Isradipine. |
Pemetrexed Injection | Pemetrexed Injection Isradipine may decrease the excretion rate of Pemetrexed which could result in a higher serum level. |
Dimenhydrinate | Dimenhydrinate The risk or severity of QTc prolongation can be increased when Isradipine is combined with Dimenhydrinate. |
Lisdexamfetamine | Lisdexamfetamine Lisdexamfetamine may decrease the antihypertensive activities of Isradipine. |
Nabilone | Nabilone The risk or severity of adverse effects can be increased when Nabilone is combined with Isradipine. |
Retapamulin | Retapamulin The metabolism of Retapamulin can be decreased when combined with Isradipine. |
Vorinostat | Vorinostat The risk or severity of QTc prolongation can be increased when Isradipine is combined with Vorinostat. |
Sorafenib | Sorafenib The metabolism of Sorafenib can be decreased when combined with Isradipine. |
Sunitinib | Sunitinib The metabolism of Sunitinib can be decreased when combined with Isradipine. |
Lapatinib | Lapatinib The risk or severity of QTc prolongation can be increased when Isradipine is combined with Lapatinib. |
Levocetirizine | Levocetirizine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Levocetirizine. |
Pegaptanib Injection | Pegaptanib Injection Isradipine may decrease the excretion rate of Pegaptanib which could result in a higher serum level. |
Dasatinib | Dasatinib The metabolism of Dasatinib can be decreased when combined with Isradipine. |
Mexiletine | Mexiletine Isradipine may increase the arrhythmogenic activities of Mexiletine. |
Azacitidine Injection | Azacitidine Injection Isradipine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Paclitaxel (with polyoxyethylated castor oil) Injection | Paclitaxel (with polyoxyethylated castor oil) Injection The therapeutic efficacy of Castor oil can be decreased when used in combination with Isradipine. |
Temsirolimus | Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Isradipine. |
Lenalidomide | Lenalidomide Isradipine may decrease the excretion rate of Lenalidomide which could result in a higher serum level. |
Nilotinib | Nilotinib The metabolism of Nilotinib can be decreased when combined with Isradipine. |
Toremifene | Toremifene The risk or severity of QTc prolongation can be increased when Isradipine is combined with Toremifene. |
Budesonide | Budesonide Isradipine may decrease the excretion rate of Budesonide which could result in a higher serum level. |
Desmopressin | Desmopressin Desmopressin may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Doripenem Injection | Doripenem Injection Isradipine may decrease the excretion rate of Doripenem which could result in a higher serum level. |
Arsenic Trioxide Injection | Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Arsenic trioxide. |
Desvenlafaxine | Desvenlafaxine Isradipine may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level. |
Cevimeline | Cevimeline Cevimeline may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Nebivolol | Nebivolol The risk or severity of bradycardia can be increased when Isradipine is combined with Nebivolol. |
Tretinoin | Tretinoin The risk or severity of adverse effects can be increased when Tretinoin is combined with Isradipine. |
Flecainide | Flecainide Isradipine may increase the arrhythmogenic activities of Flecainide. |
Certolizumab Injection | Certolizumab Injection Isradipine may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level. |
Ixabepilone Injection | Ixabepilone Injection The metabolism of Ixabepilone can be decreased when combined with Isradipine. |
Irinotecan Injection | Irinotecan Injection The metabolism of Irinotecan can be decreased when combined with Isradipine. |
Daptomycin Injection | Daptomycin Injection Daptomycin may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Methylnaltrexone Injection | Methylnaltrexone Injection Isradipine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level. |
Rufinamide | Rufinamide The metabolism of Rufinamide can be decreased when combined with Isradipine. |
Silodosin | Silodosin The risk or severity of hypotension can be increased when Silodosin is combined with Isradipine. |
Midazolam | Midazolam The serum concentration of Midazolam can be increased when it is combined with Isradipine. |
Dexrazoxane Injection | Dexrazoxane Injection Isradipine may decrease the excretion rate of Dexrazoxane which could result in a higher serum level. |
Milnacipran | Milnacipran Isradipine may decrease the excretion rate of Milnacipran which could result in a higher serum level. |
Plerixafor Injection | Plerixafor Injection Isradipine may decrease the excretion rate of Plerixafor which could result in a higher serum level. |
Sodium Phosphate | Sodium Phosphate Isradipine may increase the hyperkalemic activities of Sodium phosphate, monobasic. |
Fesoterodine | Fesoterodine Isradipine may decrease the excretion rate of Fesoterodine which could result in a higher serum level. |
Degarelix Injection | Degarelix Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Degarelix. |
Betaxolol | Betaxolol The risk or severity of bradycardia can be increased when Isradipine is combined with Betaxolol. |
Iloperidone | Iloperidone The metabolism of Iloperidone can be decreased when combined with Isradipine. |
Prasugrel | Prasugrel Isradipine may decrease the excretion rate of Prasugrel which could result in a higher serum level. |
Lacosamide | Lacosamide The metabolism of Lacosamide can be decreased when combined with Isradipine. |
Everolimus | Everolimus The metabolism of Everolimus can be decreased when combined with Isradipine. |
Tolvaptan (low blood sodium) | Tolvaptan (low blood sodium) The metabolism of Tolvaptan can be decreased when combined with Isradipine. |
Dronedarone | Dronedarone Dronedarone may increase the arrhythmogenic activities of Isradipine. |
Pralatrexate Injection | Pralatrexate Injection Isradipine may decrease the excretion rate of Pralatrexate which could result in a higher serum level. |
Palonosetron Injection | Palonosetron Injection Isradipine may decrease the excretion rate of Palonosetron which could result in a higher serum level. |
Saxagliptin | Saxagliptin The risk or severity of hypoglycemia can be increased when Isradipine is combined with Saxagliptin. |
Telavancin Injection | Telavancin Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Telavancin. |
Romidepsin Injection | Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Isradipine. |
Topotecan | Topotecan Isradipine may decrease the excretion rate of Topotecan which could result in a higher serum level. |
Pazopanib | Pazopanib The metabolism of Pazopanib can be decreased when combined with Isradipine. |
Asenapine | Asenapine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Asenapine. |
Pitavastatin | Pitavastatin Isradipine may decrease the excretion rate of Pitavastatin which could result in a higher serum level. |
Albendazole | Albendazole The metabolism of Albendazole can be decreased when combined with Isradipine. |
Liraglutide Injection | Liraglutide Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Liraglutide. |
Dalfampridine | Dalfampridine Isradipine may decrease the excretion rate of Dalfampridine which could result in a higher serum level. |
Fingolimod | Fingolimod Isradipine may increase the bradycardic activities of Fingolimod. |
Eribulin Injection | Eribulin Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Eribulin. |
Cabazitaxel Injection | Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Isradipine. |
Ceftaroline Injection | Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Lurasidone | Lurasidone The metabolism of Lurasidone can be decreased when combined with Isradipine. |
Acetaminophen Injection | Acetaminophen Injection Isradipine may decrease the excretion rate of Acetaminophen which could result in a higher serum level. |
Vilazodone | Vilazodone Vilazodone may decrease the antihypertensive activities of Isradipine. |
Ipilimumab Injection | Ipilimumab Injection Isradipine may decrease the excretion rate of Ipilimumab which could result in a higher serum level. |
Denileukin Diftitox Injection | Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Terbutaline Injection | Terbutaline Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Terbutaline. |
Azilsartan | Azilsartan The risk or severity of hyperkalemia can be increased when Isradipine is combined with Azilsartan medoxomil. |
Busulfan Injection | Busulfan Injection The metabolism of Busulfan can be decreased when combined with Isradipine. |
Roflumilast | Roflumilast The metabolism of Roflumilast can be decreased when combined with Isradipine. |
Linagliptin | Linagliptin The risk or severity of hypoglycemia can be increased when Isradipine is combined with Linagliptin. |
Rilpivirine | Rilpivirine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Rilpivirine. |
Potassium Iodide | Potassium Iodide Potassium Iodide may increase the hyperkalemic activities of Isradipine. |
Cyclophosphamide Injection | Cyclophosphamide Injection The metabolism of Cyclophosphamide can be decreased when combined with Isradipine. |
Triptorelin Injection | Triptorelin Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Triptorelin. |
Rivaroxaban | Rivaroxaban Isradipine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level. |
Brentuximab Vedotin Injection | Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Isradipine. |
Ruxolitinib | Ruxolitinib Ruxolitinib may increase the bradycardic activities of Isradipine. |
Vandetanib | Vandetanib The metabolism of Vandetanib can be decreased when combined with Isradipine. |
Clobazam | Clobazam Isradipine may decrease the excretion rate of Clobazam which could result in a higher serum level. |
Vemurafenib | Vemurafenib The risk or severity of QTc prolongation can be increased when Isradipine is combined with Vemurafenib. |
Ivacaftor | Ivacaftor The metabolism of Ivacaftor can be decreased when combined with Isradipine. |
Deferiprone | Deferiprone Isradipine may decrease the excretion rate of Deferiprone which could result in a higher serum level. |
Axitinib | Axitinib The metabolism of Axitinib can be decreased when combined with Isradipine. |
Crizotinib | Crizotinib The metabolism of Crizotinib can be decreased when combined with Isradipine. |
Cabergoline | Cabergoline The metabolism of Isradipine can be decreased when combined with Cabergoline. |
Naloxone Injection | Naloxone Injection Isradipine may decrease the excretion rate of Naloxone which could result in a higher serum level. |
Ambrisentan | Ambrisentan Isradipine may increase the hypotensive activities of Ambrisentan. |
Fondaparinux Injection | Fondaparinux Injection Isradipine may decrease the excretion rate of Fondaparinux which could result in a higher serum level. |
Iloprost | Iloprost Iloprost may increase the hypotensive activities of Isradipine. |
Enzalutamide | Enzalutamide Isradipine may decrease the excretion rate of Enzalutamide which could result in a higher serum level. |
Mirabegron | Mirabegron The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Isradipine. |
Regorafenib | Regorafenib The metabolism of Regorafenib can be decreased when combined with Isradipine. |
Bosutinib | Bosutinib The metabolism of Bosutinib can be decreased when combined with Isradipine. |
Linaclotide | Linaclotide The therapeutic efficacy of Linaclotide can be decreased when used in combination with Isradipine. |
Lorcaserin | Lorcaserin The risk or severity of hypoglycemia can be increased when Isradipine is combined with Mecasermin. |
Teduglutide Injection | Teduglutide Injection Isradipine may decrease the excretion rate of Teduglutide which could result in a higher serum level. |
Bedaquiline | Bedaquiline The risk or severity of QTc prolongation can be increased when Isradipine is combined with Bedaquiline. |
Tofacitinib | Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Isradipine. |
Alogliptin | Alogliptin The risk or severity of hypoglycemia can be increased when Isradipine is combined with Alogliptin. |
Ponatinib | Ponatinib The metabolism of Ponatinib can be decreased when combined with Isradipine. |
Pomalidomide | Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Isradipine. |
Ado-trastuzumab Emtansine Injection | Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Isradipine. |
Canagliflozin | Canagliflozin Isradipine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Methazolamide | Methazolamide Methazolamide may increase the excretion rate of Isradipine which could result in a lower serum level and potentially a reduction in efficacy. |
Dabrafenib | Dabrafenib The metabolism of Dabrafenib can be decreased when combined with Isradipine. |
Trametinib | Trametinib Isradipine may decrease the excretion rate of Trametinib which could result in a higher serum level. |
Levomilnacipran | Levomilnacipran Isradipine may decrease the excretion rate of Levomilnacipran which could result in a higher serum level. |
Ertapenem Injection | Ertapenem Injection Isradipine may decrease the excretion rate of Ertapenem which could result in a higher serum level. |
Vortioxetine | Vortioxetine Isradipine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Ibrutinib | Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Isradipine. |
Lomitapide | Lomitapide The metabolism of Lomitapide can be decreased when combined with Isradipine. |
Avanafil | Avanafil The metabolism of Avanafil can be decreased when combined with Isradipine. |
Ketorolac Injection | Ketorolac Injection The therapeutic efficacy of Isradipine can be decreased when used in combination with Ketorolac. |
Obinutuzumab Injection | Obinutuzumab Injection Isradipine may increase the hypotensive activities of Obinutuzumab. |
Simeprevir | Simeprevir Simeprevir may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Sofosbuvir | Sofosbuvir Isradipine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level. |
Dapagliflozin | Dapagliflozin Isradipine may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Apremilast | Apremilast Isradipine may decrease the excretion rate of Apremilast which could result in a higher serum level. |
Droxidopa | Droxidopa Isradipine may decrease the excretion rate of Droxidopa which could result in a higher serum level. |
Ceritinib | Ceritinib Isradipine may increase the bradycardic activities of Ceritinib. |
Albiglutide Injection | Albiglutide Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Albiglutide. |
Idelalisib | Idelalisib The metabolism of Idelalisib can be decreased when combined with Isradipine. |
Testosterone Injection | Testosterone Injection Isradipine may decrease the excretion rate of Testosterone which could result in a higher serum level. |
Empagliflozin | Empagliflozin The risk or severity of hypoglycemia can be increased when Empagliflozin is combined with Isradipine. |
Vorapaxar | Vorapaxar The metabolism of Vorapaxar can be decreased when combined with Isradipine. |
Suvorexant | Suvorexant The metabolism of Suvorexant can be decreased when combined with Isradipine. |
Dulaglutide Injection | Dulaglutide Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Dulaglutide. |
Edoxaban | Edoxaban Isradipine may decrease the excretion rate of Edoxaban which could result in a higher serum level. |
Olaparib | Olaparib The metabolism of Olaparib can be decreased when combined with Isradipine. |
Methamphetamine | Methamphetamine Isradipine may decrease the excretion rate of Metamfetamine which could result in a higher serum level. |
Tasimelteon | Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Isradipine. |
Riociguat | Riociguat Isradipine may increase the hypotensive activities of Riociguat. |
Lanreotide Injection | Lanreotide Injection Isradipine may increase the bradycardic activities of Lanreotide. |
Nintedanib | Nintedanib The metabolism of Nintedanib can be decreased when combined with Isradipine. |
Risperidone Injection | Risperidone Injection Isradipine may increase the hypotensive activities of Risperidone. |
Palbociclib | Palbociclib The metabolism of Palbociclib can be decreased when combined with Isradipine. |
Insulin Human Inhalation | Insulin Human Inhalation The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin human. |
Lenvatinib | Lenvatinib Lenvatinib may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Naloxegol | Naloxegol The metabolism of Naloxegol can be decreased when combined with Isradipine. |
Panobinostat | Panobinostat The metabolism of Panobinostat can be decreased when combined with Isradipine. |
Dinutuximab Injection | Dinutuximab Injection The risk or severity of adverse effects can be increased when Dinutuximab is combined with Isradipine. |
Haloperidol Injection | Haloperidol Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Haloperidol. |
Deoxycholic Acid Injection | Deoxycholic Acid Injection Deoxycholic acid may increase the excretion rate of Isradipine which could result in a lower serum level and potentially a reduction in efficacy. |
Ivabradine | Ivabradine The metabolism of Ivabradine can be decreased when combined with Isradipine. |
Amiloride | Amiloride Isradipine may increase the excretion rate of Amiloride which could result in a lower serum level and potentially a reduction in efficacy. |
Isavuconazonium Injection | Isavuconazonium Injection The therapeutic efficacy of Isavuconazonium can be increased when used in combination with Isradipine. |
Macitentan | Macitentan Isradipine may decrease the excretion rate of Macitentan which could result in a higher serum level. |
Sonidegib | Sonidegib The metabolism of Sonidegib can be decreased when combined with Isradipine. |
Flibanserin | Flibanserin The metabolism of Flibanserin can be decreased when combined with Isradipine. |
Brexpiprazole | Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Isradipine. |
Ziprasidone Injection | Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Ziprasidone. |
Cariprazine | Cariprazine Cariprazine may decrease the antihypertensive activities of Isradipine. |
Penicillin G Procaine Injection | Penicillin G Procaine Injection Isradipine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level. |
Insulin Degludec (rDNA Origin) Injection | Insulin Degludec (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin degludec. |
Cobimetinib | Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Isradipine. |
Trabectedin Injection | Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Isradipine. |
Osimertinib | Osimertinib The metabolism of Osimertinib can be decreased when combined with Isradipine. |
Alectinib | Alectinib The metabolism of Alectinib can be decreased when combined with Isradipine. |
Ixazomib | Ixazomib The metabolism of Ixazomib can be decreased when combined with Isradipine. |
Lesinurad | Lesinurad Isradipine may decrease the excretion rate of Lesinurad which could result in a higher serum level. |
Amphotericin B Liposomal Injection | Amphotericin B Liposomal Injection Isradipine may decrease the nephrotoxic activities of Amphotericin B. |
Dexamethasone Injection | Dexamethasone Injection Dexamethasone may increase the excretion rate of Isradipine which could result in a lower serum level and potentially a reduction in efficacy. |
Brivaracetam Injection | Brivaracetam Injection Isradipine may decrease the excretion rate of Brivaracetam which could result in a higher serum level. |
Venetoclax | Venetoclax The metabolism of Venetoclax can be decreased when combined with Isradipine. |
Midodrine | Midodrine Midodrine may increase the bradycardic activities of Isradipine. |
Selexipag | Selexipag Isradipine may increase the hypotensive activities of Selexipag. |
Diphenhydramine Injection | Diphenhydramine Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Diphenhydramine. |
Furosemide Injection | Furosemide Injection Isradipine may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy. |
Lixisenatide Injection | Lixisenatide Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Lixisenatide. |
Ribociclib | Ribociclib The risk or severity of QTc prolongation can be increased when Isradipine is combined with Ribociclib. |
Brigatinib | Brigatinib The metabolism of Brigatinib can be decreased when combined with Isradipine. |
Doxepin (Insomnia) | Doxepin (Insomnia) The risk or severity of QTc prolongation can be increased when Doxepin is combined with Isradipine. |
Plecanatide | Plecanatide The therapeutic efficacy of Plecanatide can be decreased when used in combination with Isradipine. |
Deutetrabenazine | Deutetrabenazine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Deutetrabenazine. |
Valbenazine | Valbenazine Isradipine may decrease the excretion rate of Valbenazine which could result in a higher serum level. |
Deflazacort | Deflazacort The serum concentration of Isradipine can be increased when it is combined with Deflazacort. |
Safinamide | Safinamide Safinamide may increase the hypotensive activities of Isradipine. |
Naldemedine | Naldemedine Isradipine may decrease the excretion rate of Naldemedine which could result in a higher serum level. |
Midostaurin | Midostaurin The metabolism of Midostaurin can be decreased when combined with Isradipine. |
Neratinib | Neratinib The metabolism of Neratinib can be decreased when combined with Isradipine. |
Enasidenib | Enasidenib The metabolism of Enasidenib can be decreased when combined with Isradipine. |
Aprepitant/Fosaprepitant Injection | Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be decreased when combined with Isradipine. |
Benznidazole | Benznidazole Isradipine may decrease the excretion rate of Benznidazole which could result in a higher serum level. |
Copanlisib Injection | Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Isradipine. |
Delafloxacin | Delafloxacin The risk or severity of QTc prolongation can be increased when Isradipine is combined with Delafloxacin. |
Abemaciclib | Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Isradipine. |
Acalabrutinib | Acalabrutinib The metabolism of Acalabrutinib can be decreased when combined with Isradipine. |
Letermovir | Letermovir Letermovir may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Semaglutide Injection | Semaglutide Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Semaglutide. |
Tetrabenazine | Tetrabenazine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Tetrabenazine. |
Ertugliflozin | Ertugliflozin Isradipine may increase the excretion rate of Ertugliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Apalutamide | Apalutamide Isradipine may decrease the excretion rate of Apalutamide which could result in a higher serum level. |
Fostamatinib | Fostamatinib Fostamatinib may increase the antihypertensive activities of Isradipine. |
Baricitinib | Baricitinib The metabolism of Baricitinib can be decreased when combined with Isradipine. |
Lofexidine | Lofexidine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Lofexidine. |
Plazomicin Injection | Plazomicin Injection Isradipine may decrease the excretion rate of Plazomicin which could result in a higher serum level. |
Eliglustat | Eliglustat The metabolism of Eliglustat can be decreased when combined with Isradipine. |
Encorafenib | Encorafenib The risk or severity of QTc prolongation can be increased when Isradipine is combined with Encorafenib. |
Ivosidenib | Ivosidenib The metabolism of Ivosidenib can be decreased when combined with Isradipine. |
Cannabidiol | Cannabidiol Cannabidiol may decrease the antihypertensive activities of Isradipine. |
Dacomitinib | Dacomitinib The metabolism of Dacomitinib can be decreased when combined with Isradipine. |
Duvelisib | Duvelisib The metabolism of Duvelisib can be decreased when combined with Isradipine. |
Stiripentol | Stiripentol Isradipine may decrease the excretion rate of Stiripentol which could result in a higher serum level. |
Gilteritinib | Gilteritinib The risk or severity of QTc prolongation can be increased when Isradipine is combined with Gilteritinib. |
Glasdegib | Glasdegib The risk or severity of QTc prolongation can be increased when Isradipine is combined with Glasdegib. |
Paclitaxel (with albumin) Injection | Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Isradipine. |
Prucalopride | Prucalopride The metabolism of Prucalopride can be decreased when combined with Isradipine. |
Magnesium Citrate | Magnesium Citrate The risk or severity of hypotension can be increased when Isradipine is combined with Magnesium citrate. |
Siponimod | Siponimod The risk or severity of adverse effects can be increased when Isradipine is combined with Siponimod. |
Acyclovir Ophthalmic | Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Erdafitinib | Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Isradipine. |
Alpelisib | Alpelisib The metabolism of Alpelisib can be decreased when combined with Isradipine. |
Solriamfetol | Solriamfetol Isradipine may decrease the excretion rate of Solriamfetol which could result in a higher serum level. |
Triclabendazole | Triclabendazole The risk or severity of QTc prolongation can be increased when Isradipine is combined with Triclabendazole. |
Entrectinib | Entrectinib The metabolism of Entrectinib can be decreased when combined with Isradipine. |
Pexidartinib | Pexidartinib The metabolism of Pexidartinib can be decreased when combined with Isradipine. |
Pitolisant | Pitolisant The serum concentration of Isradipine can be decreased when it is combined with Pitolisant. |
Pretomanid | Pretomanid The serum concentration of Pretomanid can be increased when it is combined with Isradipine. |
Lefamulin | Lefamulin Isradipine may increase the QTc-prolonging activities of Lefamulin. |
Phenytoin Injection | Phenytoin Injection The serum concentration of Phenytoin can be increased when it is combined with Isradipine. |
Fosphenytoin Injection | Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Isradipine. |
Zanubrutinib | Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Isradipine. |
Voxelotor | Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Isradipine. |
Lumateperone | Lumateperone The serum concentration of Lumateperone can be increased when it is combined with Isradipine. |
Lasmiditan | Lasmiditan Lasmiditan may increase the bradycardic activities of Isradipine. |
Ubrogepant | Ubrogepant The serum concentration of Ubrogepant can be increased when it is combined with Isradipine. |
Calcium Acetate | Calcium Acetate The therapeutic efficacy of Isradipine can be decreased when used in combination with Calcium acetate. |
Tazemetostat | Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Isradipine. |
Cenobamate | Cenobamate The serum concentration of Isradipine can be decreased when it is combined with Cenobamate. |
Pemigatinib | Pemigatinib The metabolism of Pemigatinib can be decreased when combined with Isradipine. |
Selumetinib | Selumetinib The serum concentration of Selumetinib can be increased when it is combined with Isradipine. |
Rimegepant | Rimegepant The metabolism of Rimegepant can be decreased when combined with Isradipine. |
Tucatinib | Tucatinib The metabolism of Tucatinib can be decreased when combined with Isradipine. |
Selpercatinib | Selpercatinib Selpercatinib may decrease the antihypertensive activities of Isradipine. |
Fostemsavir | Fostemsavir The risk or severity of QTc prolongation can be increased when Isradipine is combined with Fostemsavir. |
Lurbinectedin Injection | Lurbinectedin Injection The serum concentration of Lurbinectedin can be increased when it is combined with Isradipine. |
Octreotide | Octreotide The serum concentration of the active metabolites of Isradipine can be increased when Isradipine is used in combination with Octreotide. |
Belantamab Mafodotin-blmf Injection | Belantamab Mafodotin-blmf Injection Isradipine may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level. |
Pralsetinib | Pralsetinib Pralsetinib may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Satralizumab-mwge Injection | Satralizumab-mwge Injection The serum concentration of Isradipine can be decreased when it is combined with Satralizumab. |
Naxitamab-gqgk Injection | Naxitamab-gqgk Injection Naxitamab may decrease the antihypertensive activities of Isradipine. |
Relugolix | Relugolix The risk or severity of QTc prolongation can be increased when Isradipine is combined with Relugolix. |
Progestin-Only (drospirenone) Oral Contraceptives | Progestin-Only (drospirenone) Oral Contraceptives Isradipine may increase the excretion rate of Drospirenone which could result in a lower serum level and potentially a reduction in efficacy. |
Viloxazine | Viloxazine Isradipine may decrease the excretion rate of Viloxazine which could result in a higher serum level. |
Tobramycin Injection | Tobramycin Injection Tobramycin may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Theophylline | Theophylline The metabolism of Isradipine can be decreased when combined with Theophylline. |
Fenoprofen | Fenoprofen The therapeutic efficacy of Isradipine can be decreased when used in combination with Fenoprofen. |
Indomethacin | Indomethacin Isradipine may decrease the excretion rate of Indomethacin which could result in a higher serum level. |
Mefenamic Acid | Mefenamic Acid The therapeutic efficacy of Isradipine can be decreased when used in combination with Mefenamic acid. |
Naproxen | Naproxen The therapeutic efficacy of Isradipine can be decreased when used in combination with Naproxen. |
Tolmetin | Tolmetin The therapeutic efficacy of Isradipine can be decreased when used in combination with Tolmetin. |
Sulindac | Sulindac The therapeutic efficacy of Isradipine can be decreased when used in combination with Sulindac. |
Trazodone | Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Isradipine. |
Isotretinoin | Isotretinoin Isradipine may decrease the excretion rate of Isotretinoin which could result in a higher serum level. |
Sucralfate | Sucralfate Isradipine may decrease the excretion rate of Sucralfate which could result in a higher serum level. |
Floxuridine | Floxuridine Isradipine may decrease the excretion rate of Floxuridine which could result in a higher serum level. |
Phenobarbital | Phenobarbital Phenobarbital may increase the excretion rate of Isradipine which could result in a lower serum level and potentially a reduction in efficacy. |
Metaxalone | Metaxalone Isradipine may decrease the excretion rate of Metaxalone which could result in a higher serum level. |
Methotrexate Injection | Methotrexate Injection The metabolism of Isradipine can be decreased when combined with Methotrexate. |
Primidone | Primidone The metabolism of Isradipine can be increased when combined with Primidone. |
Methsuximide | Methsuximide Isradipine may increase the arrhythmogenic activities of Methsuximide. |
Diethylpropion | Diethylpropion Diethylpropion may decrease the antihypertensive activities of Isradipine. |
Chlorpromazine | Chlorpromazine Chlorpromazine may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Diazepam | Diazepam Isradipine may decrease the excretion rate of Diazepam which could result in a higher serum level. |
Oxazepam | Oxazepam Isradipine may decrease the excretion rate of Oxazepam which could result in a higher serum level. |
Flurazepam | Flurazepam Isradipine may decrease the excretion rate of Flurazepam which could result in a higher serum level. |
Clorazepate | Clorazepate Isradipine may decrease the excretion rate of Clorazepic acid which could result in a higher serum level. |
Lorazepam | Lorazepam The metabolism of Isradipine can be decreased when combined with Lorazepam. |
Phenoxybenzamine | Phenoxybenzamine The risk or severity of hypotension can be increased when Phenoxybenzamine is combined with Isradipine. |
Carmustine | Carmustine Carmustine may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Amantadine | Amantadine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Amantadine. |
Codeine | Codeine Isradipine may decrease the excretion rate of Codeine which could result in a higher serum level. |
Bromocriptine | Bromocriptine The risk or severity of hypotension can be increased when Bromocriptine is combined with Isradipine. |
Metaproterenol | Metaproterenol Orciprenaline may decrease the antihypertensive activities of Isradipine. |
Tranylcypromine | Tranylcypromine Tranylcypromine may increase the hypotensive activities of Isradipine. |
Phenelzine | Phenelzine Phenelzine may increase the hypotensive activities of Isradipine. |
Procarbazine | Procarbazine Procarbazine may increase the hypotensive activities of Isradipine. |
Ergoloid Mesylates | Ergoloid Mesylates Ergoloid mesylate may decrease the antihypertensive activities of Isradipine. |
Tetracycline | Tetracycline Isradipine may decrease the excretion rate of Tetracycline which could result in a higher serum level. |
Prochlorperazine | Prochlorperazine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Prochlorperazine. |
Thioridazine | Thioridazine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Thioridazine. |
Trifluoperazine | Trifluoperazine The risk or severity of hypotension can be increased when Trifluoperazine is combined with Isradipine. |
Bleomycin | Bleomycin Isradipine may decrease the excretion rate of Bleomycin which could result in a higher serum level. |
Sulfadiazine | Sulfadiazine The risk or severity of hypoglycemia can be increased when Isradipine is combined with Sulfadiazine. |
Methadone | Methadone The risk or severity of QTc prolongation can be increased when Isradipine is combined with Methadone. |
Benztropine | Benztropine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Isradipine. |
Maprotiline | Maprotiline The risk or severity of QTc prolongation can be increased when Isradipine is combined with Maprotiline. |
Ibuprofen | Ibuprofen Ibuprofen may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Orphenadrine | Orphenadrine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Orphenadrine. |
Azathioprine | Azathioprine Isradipine may decrease the excretion rate of Azathioprine which could result in a higher serum level. |
Phentermine | Phentermine The metabolism of Phentermine can be decreased when combined with Isradipine. |
Methylphenidate | Methylphenidate Methylphenidate may decrease the antihypertensive activities of Isradipine. |
Amoxapine | Amoxapine The risk or severity of hypotension can be increased when Amoxapine is combined with Isradipine. |
Sulfasalazine | Sulfasalazine Sulfasalazine may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Doxorubicin | Doxorubicin The metabolism of Doxorubicin can be decreased when combined with Isradipine. |
Phenazopyridine | Phenazopyridine Phenazopyridine may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Carbamazepine | Carbamazepine The metabolism of Carbamazepine can be decreased when combined with Isradipine. |
Methyldopa | Methyldopa Isradipine may decrease the excretion rate of Methyldopa which could result in a higher serum level. |
Clonidine | Clonidine Clonidine may increase the atrioventricular blocking (AV block) activities of Isradipine. |
Prazosin | Prazosin The risk or severity of hypotension can be increased when Prazosin is combined with Isradipine. |
Hydralazine | Hydralazine Isradipine may decrease the excretion rate of Hydralazine which could result in a higher serum level. |
Cimetidine | Cimetidine The serum concentration of Isradipine can be increased when it is combined with Cimetidine. |
Gentamicin Injection | Gentamicin Injection Gentamicin may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Warfarin | Warfarin The serum concentration of Warfarin can be increased when it is combined with Isradipine. |
Clonazepam | Clonazepam Isradipine may decrease the excretion rate of Clonazepam which could result in a higher serum level. |
Loperamide | Loperamide Isradipine may increase the arrhythmogenic activities of Loperamide. |
Promethazine | Promethazine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Promethazine. |
Meclofenamate | Meclofenamate The therapeutic efficacy of Isradipine can be decreased when used in combination with Meclofenamic acid. |
Daunorubicin | Daunorubicin Isradipine may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Nitrofurantoin | Nitrofurantoin Isradipine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level. |
Digoxin | Digoxin Isradipine may increase the arrhythmogenic activities of Digoxin. |
Chloroquine | Chloroquine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Chloroquine. |
Quinine | Quinine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Quinine. |
Ethosuximide | Ethosuximide Isradipine may increase the arrhythmogenic activities of Ethosuximide. |
Triamterene | Triamterene Isradipine may decrease the excretion rate of Triamterene which could result in a higher serum level. |
Lactulose | Lactulose The therapeutic efficacy of Lactulose can be decreased when used in combination with Isradipine. |
Sulfinpyrazone | Sulfinpyrazone Isradipine may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level. |
Chlorothiazide | Chlorothiazide The therapeutic efficacy of Chlorothiazide can be increased when used in combination with Isradipine. |
Chlorthalidone | Chlorthalidone Isradipine may increase the excretion rate of Chlorthalidone which could result in a lower serum level and potentially a reduction in efficacy. |
Metolazone | Metolazone Isradipine may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy. |
Isosorbide | Isosorbide Isosorbide may increase the vasodilatory activities of Isradipine. |
Secobarbital | Secobarbital The metabolism of Isradipine can be increased when combined with Secobarbital. |
Desipramine | Desipramine The risk or severity of QTc prolongation can be increased when Desipramine is combined with Isradipine. |
Amitriptyline | Amitriptyline The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Isradipine. |
Imipramine | Imipramine The risk or severity of QTc prolongation can be increased when Imipramine is combined with Isradipine. |
Probenecid | Probenecid Isradipine may decrease the excretion rate of Probenecid which could result in a higher serum level. |
Quinidine | Quinidine Isradipine may increase the arrhythmogenic activities of Quinidine. |
Procainamide | Procainamide Isradipine may increase the arrhythmogenic activities of Procainamide. |
Isoniazid | Isoniazid Isradipine may decrease the excretion rate of Isoniazid which could result in a higher serum level. |
Pyrazinamide | Pyrazinamide Isradipine may decrease the excretion rate of Pyrazinamide which could result in a higher serum level. |
Rifampin | Rifampin Rifampicin may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Disopyramide | Disopyramide Isradipine may increase the arrhythmogenic activities of Disopyramide. |
Valproic Acid | Valproic Acid The risk or severity of QTc prolongation can be increased when Isradipine is combined with Valproic acid. |
Tamoxifen | Tamoxifen The metabolism of Isradipine can be decreased when combined with Tamoxifen. |
Butabarbital | Butabarbital Butabarbital may increase the hypotensive activities of Isradipine. |
Liothyronine | Liothyronine Isradipine may decrease the excretion rate of Liothyronine which could result in a higher serum level. |
Methimazole | Methimazole Isradipine may decrease the excretion rate of Methimazole which could result in a higher serum level. |
Chlorpropamide | Chlorpropamide The risk or severity of hypoglycemia can be increased when Isradipine is combined with Chlorpropamide. |
Tolbutamide | Tolbutamide The risk or severity of hypoglycemia can be increased when Isradipine is combined with Tolbutamide. |
Tolazamide | Tolazamide The risk or severity of hypoglycemia can be increased when Isradipine is combined with Tolazamide. |
Baclofen | Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Isradipine. |
Doxylamine | Doxylamine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Doxylamine. |
Cyproheptadine | Cyproheptadine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Cyproheptadine. |
Clemastine | Clemastine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Clemastine. |
Chlorpheniramine | Chlorpheniramine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Chlorpheniramine. |
Brompheniramine | Brompheniramine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Dexbrompheniramine. |
Ethambutol | Ethambutol Isradipine may decrease the excretion rate of Ethambutol which could result in a higher serum level. |
Methyclothiazide | Methyclothiazide The therapeutic efficacy of Isradipine can be increased when used in combination with Methyclothiazide. |
Hydrochlorothiazide | Hydrochlorothiazide The therapeutic efficacy of Isradipine can be increased when used in combination with Hydrochlorothiazide. |
Dantrolene | Dantrolene The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Isradipine. |
Chlorzoxazone | Chlorzoxazone Isradipine may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level. |
Pyridoxine | Pyridoxine Pyridoxine may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Folic Acid | Folic Acid Folic acid may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Disulfiram | Disulfiram The risk or severity of QTc prolongation can be increased when Isradipine is combined with Disulfiram. |
Propranolol (Cardiovascular) | Propranolol (Cardiovascular) The risk or severity of bradycardia can be increased when Isradipine is combined with Propranolol. |
Minoxidil | Minoxidil Isradipine may increase the hypotensive activities of Minoxidil. |
Pseudoephedrine | Pseudoephedrine Pseudoephedrine may decrease the antihypertensive activities of Isradipine. |
Nortriptyline | Nortriptyline The metabolism of Isradipine can be decreased when combined with Nortriptyline. |
Spironolactone | Spironolactone Isradipine may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy. |
Amphotericin B Injection | Amphotericin B Injection Isradipine may decrease the nephrotoxic activities of Amphotericin B. |
Phytonadione | Phytonadione Isradipine may decrease the excretion rate of Phylloquinone which could result in a higher serum level. |
Amikacin Injection | Amikacin Injection Amikacin may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Nadolol | Nadolol The risk or severity of bradycardia can be increased when Isradipine is combined with Nadolol. |
Allopurinol | Allopurinol Isradipine may decrease the excretion rate of Allopurinol which could result in a higher serum level. |
Oxytocin Injection | Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Isradipine. |
Flavoxate | Flavoxate Isradipine may decrease the excretion rate of Flavoxate which could result in a higher serum level. |
Papaverine | Papaverine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Papaverine. |
Fluorouracil Injection | Fluorouracil Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Fluorouracil. |
Colchicine | Colchicine The metabolism of Colchicine can be decreased when combined with Isradipine. |
Cefaclor | Cefaclor Cefaclor may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Cefadroxil | Cefadroxil Cefadroxil may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Cefazolin Injection | Cefazolin Injection Cefazolin may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Cephalexin | Cephalexin Cephalexin may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Cefoxitin Injection | Cefoxitin Injection Cefoxitin may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Dacarbazine | Dacarbazine Isradipine may decrease the excretion rate of Dacarbazine which could result in a higher serum level. |
Acetazolamide | Acetazolamide Acetazolamide may increase the excretion rate of Isradipine which could result in a lower serum level and potentially a reduction in efficacy. |
Cefotaxime Injection | Cefotaxime Injection Cefotaxime may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Calcitonin Salmon Injection | Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Ketoconazole | Ketoconazole Ketoconazole may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Pyrantel | Pyrantel Isradipine may decrease the excretion rate of Pyrantel which could result in a higher serum level. |
Thiotepa Injection | Thiotepa Injection The metabolism of Thiotepa can be decreased when combined with Isradipine. |
Vincristine Injection | Vincristine Injection The metabolism of Vincristine can be decreased when combined with Isradipine. |
Captopril | Captopril The risk or severity of hyperkalemia can be increased when Isradipine is combined with Captopril. |
Dipyridamole | Dipyridamole Dipyridamole may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Isoxsuprine | Isoxsuprine Isoxsuprine may decrease the antihypertensive activities of Isradipine. |
Vinblastine | Vinblastine The metabolism of Isradipine can be decreased when combined with Vinblastine. |
Ethacrynic Acid | Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Colistimethate Injection | Colistimethate Injection Colistimethate may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Metoprolol | Metoprolol The risk or severity of bradycardia can be increased when Isradipine is combined with Metoprolol. |
Hydroxyzine | Hydroxyzine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Hydroxyzine. |
Thiothixene | Thiothixene The risk or severity of QTc prolongation can be increased when Isradipine is combined with Thiothixene. |
Aspirin | Aspirin Acetylsalicylic acid may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Salsalate | Salsalate The therapeutic efficacy of Isradipine can be decreased when used in combination with Salsalate. |
Alprazolam | Alprazolam The metabolism of Alprazolam can be decreased when combined with Isradipine. |
Temazepam | Temazepam Temazepam may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Triazolam | Triazolam Isradipine may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Dicyclomine | Dicyclomine Isradipine may decrease the excretion rate of Dicyclomine which could result in a higher serum level. |
Hyoscyamine | Hyoscyamine Isradipine may increase the arrhythmogenic activities of Hyoscyamine. |
Propantheline | Propantheline Isradipine may decrease the excretion rate of Propantheline which could result in a higher serum level. |
Trimethoprim | Trimethoprim The risk or severity of hyperkalemia can be increased when Isradipine is combined with Trimethoprim. |
Diltiazem | Diltiazem Isradipine may increase the arrhythmogenic activities of Diltiazem. |
Nifedipine | Nifedipine Isradipine may increase the arrhythmogenic activities of Nifedipine. |
Timolol | Timolol The risk or severity of adverse effects can be increased when Isradipine is combined with Timolol. |
Verapamil | Verapamil Verapamil may increase the arrhythmogenic activities of Isradipine. |
Atenolol | Atenolol The risk or severity of bradycardia can be increased when Isradipine is combined with Atenolol. |
Pindolol | Pindolol The risk or severity of bradycardia can be increased when Isradipine is combined with Pindolol. |
Cisplatin Injection | Cisplatin Injection Isradipine may decrease the excretion rate of Cisplatin which could result in a higher serum level. |
Diflunisal | Diflunisal Diflunisal may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Piroxicam | Piroxicam The therapeutic efficacy of Isradipine can be decreased when used in combination with Piroxicam. |
Bumetanide | Bumetanide Isradipine may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy. |
Etoposide | Etoposide The metabolism of Etoposide can be decreased when combined with Isradipine. |
Glyburide | Glyburide Glyburide may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Glipizide | Glipizide The risk or severity of hypoglycemia can be increased when Isradipine is combined with Glipizide. |
Indapamide | Indapamide The therapeutic efficacy of Indapamide can be increased when used in combination with Isradipine. |
Amoxicillin | Amoxicillin Isradipine may decrease the excretion rate of Amoxicillin which could result in a higher serum level. |
Nafcillin Injection | Nafcillin Injection The therapeutic efficacy of Isradipine can be decreased when used in combination with Nafcillin. |
Oxacillin Injection | Oxacillin Injection Isradipine may decrease the excretion rate of Oxacillin which could result in a higher serum level. |
Pentoxifylline | Pentoxifylline Pentoxifylline may increase the hypotensive activities of Isradipine. |
Pentamidine Injection | Pentamidine Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Pentamidine. |
Ceftriaxone Injection | Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Labetalol | Labetalol The risk or severity of bradycardia can be increased when Labetalol is combined with Isradipine. |
Auranofin | Auranofin Isradipine may decrease the excretion rate of Auranofin which could result in a higher serum level. |
Leuprolide Injection | Leuprolide Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Leuprolide. |
Gemfibrozil | Gemfibrozil Isradipine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level. |
Guanabenz | Guanabenz Isradipine may decrease the antihypertensive activities of Guanabenz. |
Dipivefrin Ophthalmic | Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Ceftazidime Injection | Ceftazidime Injection Ceftazidime may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Ketoprofen | Ketoprofen The therapeutic efficacy of Isradipine can be decreased when used in combination with Ketoprofen. |
Cefotetan Injection | Cefotetan Injection Cefotetan may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Pimozide | Pimozide The metabolism of Pimozide can be decreased when combined with Isradipine. |
Enalapril | Enalapril The risk or severity of hyperkalemia can be increased when Isradipine is combined with Enalapril. |
Flurbiprofen | Flurbiprofen The therapeutic efficacy of Isradipine can be decreased when used in combination with Flurbiprofen. |
Amiodarone | Amiodarone The risk or severity of adverse effects can be increased when Isradipine is combined with Amiodarone. |
Aztreonam Injection | Aztreonam Injection Isradipine may decrease the excretion rate of Aztreonam which could result in a higher serum level. |
Buspirone | Buspirone Buspirone may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Lovastatin | Lovastatin The metabolism of Lovastatin can be decreased when combined with Isradipine. |
Ciprofloxacin | Ciprofloxacin The risk or severity of QTc prolongation can be increased when Isradipine is combined with Ciprofloxacin. |
Mesalamine | Mesalamine Mesalazine may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Diclofenac | Diclofenac The therapeutic efficacy of Isradipine can be decreased when used in combination with Diclofenac. |
Fluoxetine | Fluoxetine The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Isradipine. |
Nimodipine | Nimodipine Isradipine may increase the arrhythmogenic activities of Nimodipine. |
Clozapine | Clozapine The risk or severity of hypotension can be increased when Clozapine is combined with Isradipine. |
Estazolam | Estazolam Isradipine may decrease the excretion rate of Estazolam which could result in a higher serum level. |
Ofloxacin | Ofloxacin The risk or severity of QTc prolongation can be increased when Isradipine is combined with Ofloxacin. |
Didanosine | Didanosine Isradipine may decrease the excretion rate of Didanosine which could result in a higher serum level. |
Pentostatin Injection | Pentostatin Injection Isradipine may decrease the excretion rate of Pentostatin which could result in a higher serum level. |
Clarithromycin | Clarithromycin Isradipine may decrease the excretion rate of Clarithromycin which could result in a higher serum level. |
Benazepril | Benazepril The risk or severity of hyperkalemia can be increased when Isradipine is combined with Benazepril. |
Etodolac | Etodolac The therapeutic efficacy of Isradipine can be decreased when used in combination with Etodolac. |
Felodipine | Felodipine Isradipine may increase the arrhythmogenic activities of Felodipine. |
Fosinopril | Fosinopril The risk or severity of hyperkalemia can be increased when Isradipine is combined with Fosinopril. |
Nabumetone | Nabumetone The therapeutic efficacy of Isradipine can be decreased when used in combination with Nabumetone. |
Pravastatin | Pravastatin Pravastatin may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Quinapril | Quinapril The risk or severity of hyperkalemia can be increased when Isradipine is combined with Quinapril. |
Ramipril | Ramipril The risk or severity of hyperkalemia can be increased when Ramipril is combined with Isradipine. |
Simvastatin | Simvastatin Isradipine may decrease the excretion rate of Simvastatin which could result in a higher serum level. |
Amlodipine | Amlodipine Isradipine may increase the arrhythmogenic activities of Amlodipine. |
Teniposide Injection | Teniposide Injection The metabolism of Teniposide can be decreased when combined with Isradipine. |
Itraconazole | Itraconazole The risk or severity of QTc prolongation can be increased when Isradipine is combined with Itraconazole. |
Lisinopril | Lisinopril The risk or severity of hyperkalemia can be increased when Isradipine is combined with Lisinopril. |
Oxaprozin | Oxaprozin The therapeutic efficacy of Isradipine can be decreased when used in combination with Oxaprozin. |
Sotalol | Sotalol The risk or severity of bradycardia can be increased when Isradipine is combined with Sotalol. |
Bisoprolol | Bisoprolol The therapeutic efficacy of Isradipine can be increased when used in combination with Bisoprolol. |
Doxazosin | Doxazosin The risk or severity of hypotension can be increased when Doxazosin is combined with Isradipine. |
Terazosin | Terazosin The risk or severity of hypotension can be increased when Terazosin is combined with Isradipine. |
Cisapride | Cisapride The metabolism of Cisapride can be decreased when combined with Isradipine. |
Venlafaxine | Venlafaxine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Venlafaxine. |
Famciclovir | Famciclovir The metabolism of Famciclovir can be decreased when combined with Isradipine. |
Fluvoxamine | Fluvoxamine Fluvoxamine may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Nefazodone | Nefazodone Nefazodone may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Lamotrigine | Lamotrigine Isradipine may increase the arrhythmogenic activities of Lamotrigine. |
Losartan | Losartan Isradipine may increase the arrhythmogenic activities of Losartan. |
Valacyclovir | Valacyclovir Valaciclovir may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Tramadol | Tramadol The metabolism of Tramadol can be decreased when combined with Isradipine. |
Vinorelbine Injection | Vinorelbine Injection The metabolism of Vinorelbine can be decreased when combined with Isradipine. |
Carboplatin Injection | Carboplatin Injection Carboplatin may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Moexipril | Moexipril The risk or severity of QTc prolongation can be increased when Isradipine is combined with Moexipril. |
Ifosfamide Injection | Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Isradipine. |
Nicardipine | Nicardipine Isradipine may increase the arrhythmogenic activities of Nicardipine. |
Bupropion | Bupropion Isradipine may decrease the excretion rate of Bupropion which could result in a higher serum level. |
Ticlopidine | Ticlopidine The metabolism of Isradipine can be decreased when combined with Ticlopidine. |
Saquinavir | Saquinavir The risk or severity of QTc prolongation can be increased when Isradipine is combined with Saquinavir. |
Metformin | Metformin The risk or severity of hypoglycemia can be increased when Isradipine is combined with Metformin. |
Dalteparin Injection | Dalteparin Injection The risk or severity of hyperkalemia can be increased when Isradipine is combined with Dalteparin. |
Nisoldipine | Nisoldipine Isradipine may increase the arrhythmogenic activities of Nisoldipine. |
Lamivudine | Lamivudine Isradipine may decrease the excretion rate of Lamivudine which could result in a higher serum level. |
Amifostine Injection | Amifostine Injection Isradipine may increase the hypotensive activities of Amifostine. |
Acarbose | Acarbose The risk or severity of hypoglycemia can be increased when Isradipine is combined with Acarbose. |
Glimepiride | Glimepiride Glimepiride may increase the arrhythmogenic activities of Isradipine. |
Gemcitabine Injection | Gemcitabine Injection Isradipine may decrease the excretion rate of Gemcitabine which could result in a higher serum level. |
Indinavir | Indinavir Indinavir may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Ritonavir | Ritonavir The serum concentration of Ritonavir can be increased when it is combined with Isradipine. |
Docetaxel Injection | Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Isradipine. |
Cidofovir Injection | Cidofovir Injection Cidofovir may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Meropenem Injection | Meropenem Injection Isradipine may decrease the excretion rate of Meropenem which could result in a higher serum level. |
Clomipramine | Clomipramine The metabolism of Isradipine can be decreased when combined with Clomipramine. |
Zafirlukast | Zafirlukast The metabolism of Isradipine can be decreased when combined with Zafirlukast. |
Fosfomycin | Fosfomycin Isradipine may decrease the excretion rate of Fosfomycin which could result in a higher serum level. |
Mirtazapine | Mirtazapine The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Isradipine. |
Trandolapril | Trandolapril The risk or severity of hyperkalemia can be increased when Isradipine is combined with Trandolapril. |
Topiramate | Topiramate Isradipine may decrease the excretion rate of Topiramate which could result in a higher serum level. |
Valsartan | Valsartan The risk or severity of hyperkalemia can be increased when Valsartan is combined with Isradipine. |
Insulin Lispro Injection | Insulin Lispro Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin lispro. |
Pramipexole | Pramipexole Isradipine may decrease the excretion rate of Pramipexole which could result in a higher serum level. |
Donepezil | Donepezil Isradipine may increase the bradycardic activities of Donepezil. |
Nelfinavir | Nelfinavir Nelfinavir may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Azithromycin | Azithromycin The risk or severity of QTc prolongation can be increased when Isradipine is combined with Azithromycin. |
Loratadine | Loratadine Isradipine may decrease the excretion rate of Loratadine which could result in a higher serum level. |
Carvedilol | Carvedilol The risk or severity of bradycardia can be increased when Carvedilol is combined with Isradipine. |
Nilutamide | Nilutamide Isradipine may decrease the excretion rate of Nilutamide which could result in a higher serum level. |
Flutamide | Flutamide Isradipine may decrease the excretion rate of Flutamide which could result in a higher serum level. |
Selegiline | Selegiline Selegiline may increase the hypotensive activities of Isradipine. |
Bicalutamide | Bicalutamide The metabolism of Bicalutamide can be decreased when combined with Isradipine. |
Propafenone | Propafenone The risk or severity of bradycardia can be increased when Isradipine is combined with Propafenone. |
Irbesartan | Irbesartan The risk or severity of hyperkalemia can be increased when Isradipine is combined with Irbesartan. |
Tamsulosin | Tamsulosin The risk or severity of hypotension can be increased when Isradipine is combined with Tamsulosin. |
Ropinirole | Ropinirole The risk or severity of adverse effects can be increased when Ropinirole is combined with Isradipine. |
Finasteride | Finasteride Finasteride may decrease the antihypertensive activities of Isradipine. |
Quetiapine | Quetiapine Isradipine may increase the hypotensive activities of Quetiapine. |
Cefepime Injection | Cefepime Injection Cefepime may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Cefprozil | Cefprozil Cefprozil may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Cefpodoxime | Cefpodoxime Cefpodoxime may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Cetirizine | Cetirizine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Cetirizine. |
Tolcapone | Tolcapone Isradipine may decrease the excretion rate of Tolcapone which could result in a higher serum level. |
Citalopram | Citalopram The risk or severity of QTc prolongation can be increased when Isradipine is combined with Citalopram. |
Capecitabine | Capecitabine Isradipine may decrease the excretion rate of Capecitabine which could result in a higher serum level. |
Efavirenz | Efavirenz The serum concentration of Isradipine can be decreased when it is combined with Efavirenz. |
Abacavir | Abacavir Isradipine may decrease the excretion rate of Abacavir which could result in a higher serum level. |
Sildenafil | Sildenafil Sildenafil may increase the antihypertensive activities of Isradipine. |
Pioglitazone | Pioglitazone The risk or severity of hypoglycemia can be increased when Isradipine is combined with Pioglitazone. |
Celecoxib | Celecoxib The therapeutic efficacy of Isradipine can be decreased when used in combination with Celecoxib. |
Rosiglitazone | Rosiglitazone The risk or severity of hypoglycemia can be increased when Isradipine is combined with Rosiglitazone. |
Tolterodine | Tolterodine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Tolterodine. |
Thalidomide | Thalidomide The risk or severity of adverse effects can be increased when Thalidomide is combined with Isradipine. |
Oseltamivir | Oseltamivir Oseltamivir may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Balsalazide | Balsalazide Balsalazide may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Nateglinide | Nateglinide The risk or severity of hypoglycemia can be increased when Isradipine is combined with Nateglinide. |
Galantamine | Galantamine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Galantamine. |
Rabeprazole | Rabeprazole Isradipine may decrease the excretion rate of Rabeprazole which could result in a higher serum level. |
Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists